Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYHS2401485	利伐沙班干混悬剂	rivaroxaban	Suspension	Chemical Drugs(4)	Generic Drug	2024-05-17	Nanjing Healthnice Pharmaceutical Co Ltd	view
CYHS2401486	利伐沙班干混悬剂	rivaroxaban	Suspension	Chemical Drugs(4)	Generic Drug	2024-05-17	Nanjing Healthnice Pharmaceutical Co Ltd	view
JYHB2200568	利伐沙班干混悬剂	rivaroxaban	Suspension	Chemical Drugs(2.2)	Supplementary Application	2022-10-20	Bayer AG	view
JYHB2200567	利伐沙班干混悬剂	rivaroxaban	Suspension	Chemical Drugs(2.2)	Supplementary Application	2022-10-20	Bayer AG	view